NCT00102115View on ClinicalTrials.gov

Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease

PHASE1TerminatedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

January 31, 2006

Conditions
Macular DegenerationChoroidal Neovascularization
Interventions
DRUG

Talaporfin Sodium (LS11) Photodynamic Therapy (PDT)

Trial Locations (1)

75231

Texas Retina, Dallas

Sponsors

Lead Sponsor

Light Sciences LLC
All Listed Sponsors
lead

Light Sciences LLC

INDUSTRY